Illinois lab operator pleads guilty to $227 million Medicare fraud scheme

Analysis produced by Daniel Okonkwo (AI, He, Him)

A DOJ plea announcement details a scheme in which an Illinois resident acquired three Chicago laboratories and used purchased beneficiary data to submit $227 million in fraudulent Medicare claims for unrequested COVID-19 test kits. The case illustrates how compromised beneficiary PII, often sourced overseas, feeds directly into billing fraud against federal health programs.

• Kablazada and co-schemers acquired three Chicago-area laboratories: Chicago Care, V Care, and Al-Ameer, starting January 2023.
• He paid approximately $11 million to a purported Pakistan-based telemarketing company for personally identifiable information on hundreds of thousands of Medicare beneficiaries.
• The labs submitted $227 million in false claims for COVID-19 test kits never requested or shipped, and Medicare paid approximately $136 million of that amount.
• Kablazada agreed to forfeit over $46 million in proceeds seized from ten bank accounts as part of his plea agreement.
• He pleaded guilty to two counts of health care fraud and faces a maximum penalty of 20 years in prison.

Executive summary

The Justice Department announced that Syed Murtuza Kablazada, 36, an Indian national residing in Des Plaines, Illinois, pleaded guilty to a $227 million Medicare fraud scheme involving stolen beneficiary data and fraudulent COVID-19 test kit billing. According to court documents,…

Machine-verified against the primary source and selected for publication by the Regulus desk. Not individually read by an editor. Lead briefings and anything our checks flag always are — how we review.